Compounds > b 669
Page last updated: 2024-09-04

b 669 and lysophosphatidylcholines

b 669 has been researched along with lysophosphatidylcholines in 3 studies

Compound Research Comparison

Studies
(b 669)		Trials
(b 669)		Recent Studies (post-2010)
(b 669)		Studies
(lysophosphatidylcholines)		Trials
(lysophosphatidylcholines)		Recent Studies (post-2010) (lysophosphatidylcholines)
16005,05839976

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, R; Van Rensburg, CE; Van Staden, AM1
Anderson, R; Prinsloo, Y; van der Walt, R; van Rensburg, CE1
Anderson, R; De Bruyn, EE; Steel, HC; Van Rensburg, EJ1

Other Studies

3 other study(ies) available for b 669 and lysophosphatidylcholines

ArticleYear
The riminophenazine agents clofazimine and B669 inhibit the proliferation of cancer cell lines in vitro by phospholipase A2-mediated oxidative and nonoxidative mechanisms.
    Cancer research, 1993, Jan-15, Volume: 53, Issue:2

    Topics: Animals; Arachidonic Acid; Bleomycin; Cell Death; Cell Division; Cisplatin; Clofazimine; Cyclooxygenase Inhibitors; Cytotoxicity, Immunologic; Growth Inhibitors; Humans; In Vitro Techniques; L-Lactate Dehydrogenase; Lipoxygenase Inhibitors; Lysophosphatidylcholines; Methotrexate; Neutrophils; Oxidation-Reduction; Phospholipases A; Phospholipases A2; Protein Kinase C; Tumor Cells, Cultured; Vitamin E

1993
Augmentative inhibition of lymphocyte proliferation by cyclosporin A combined with the riminophenazine compounds clofazimine and B669.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 1995, Volume: 44, Issue:9

    Topics: Adenosine Triphosphate; Adult; Arachidonic Acid; Clofazimine; Cyclosporine; Drug Synergism; Humans; Immunosuppressive Agents; Lymphocyte Activation; Lysophosphatidylcholines; Sodium-Potassium-Exchanging ATPase

1995
The riminophenazines, clofazimine and B669, inhibit potassium transport in gram-positive bacteria by a lysophospholipid-dependent mechanism.
    The Journal of antimicrobial chemotherapy, 1996, Volume: 38, Issue:3

    Topics: Adenosine Triphosphate; Anti-Bacterial Agents; Biological Transport; Clofazimine; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Lysophosphatidylcholines; Lysophospholipids; Mutation; Potassium; Potassium Radioisotopes; Rubidium Radioisotopes; Vitamin E

1996